The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4 –5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, mela...

Source: Journal of Hematology and Oncology - March 20, 2018 Category: Hematology Authors: Cunzhen Shi, Xiangqun Li, Xiaogan Wang, Ning Ding, Lingyan Ping, Yunfei Shi, Lan Mi, Yumei Lai, Yuqin Song and Jun Zhu Tags: Research Source Type: research